Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition
about
Mammary stem cells, self-renewal pathways, and carcinogenesisRal is both necessary and sufficient for the inhibition of myeloid differentiation mediated by RasBypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells.Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells.Pleiotrophin mediates hematopoietic regeneration via activation of RAS.A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutantsFrom top to bottom: midkine and pleiotrophin as emerging players in immune regulation.Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.Eicosapentaenoic acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells.Autologous serum improves yield and metabolic capacity of monocyte-derived hepatocyte-like cells: possible implication for cell transplantation.Wild-type Kras expands and exhausts hematopoietic stem cells.
P2860
Q24529145-A56CB4B2-F4DE-484A-ACD7-AD13750B01EBQ33241589-21531408-F689-46CC-B593-246A9CC5353DQ34335191-88018D56-B7C0-4E6E-8A7E-41FA35E60E0CQ34480237-783CA902-11A6-4587-B8E4-FA1E5A4AD4A0Q35140111-17A9D4C4-419C-46A6-9307-2F2E8F7E704CQ35692793-BB349E7F-1D5C-46BB-B322-00B73E92363DQ35847802-21FA1AA2-BF71-43DE-851C-0ACA7DA2297FQ37081990-30867FF6-51F8-4193-861D-A8FC5F210E16Q37302271-888A881F-7648-471A-AF79-6CE85089D893Q39207404-915DB15B-C6B1-4CE5-B590-CF781CFC41B4Q40423639-EE898984-8868-426B-B37D-E9083F107A39Q41869019-784A6E12-7CB0-43F3-A047-EC19E35A3BA0Q45812153-D7984DE2-6FBC-4761-ACED-08A7049D5248Q54976859-BCBF3982-8F39-4350-85FA-AB62DF229915
P2860
Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hematopoietic cell fate and th ...... farnesyltransferase inhibition
@ast
Hematopoietic cell fate and th ...... farnesyltransferase inhibition
@en
type
label
Hematopoietic cell fate and th ...... farnesyltransferase inhibition
@ast
Hematopoietic cell fate and th ...... farnesyltransferase inhibition
@en
prefLabel
Hematopoietic cell fate and th ...... farnesyltransferase inhibition
@ast
Hematopoietic cell fate and th ...... farnesyltransferase inhibition
@en
P2093
P2860
P1476
Hematopoietic cell fate and th ...... farnesyltransferase inhibition
@en
P2093
Craig Dorrell
Katsuto Takenaka
Mark D Minden
P2860
P304
P356
10.1128/MCB.24.16.6993-7002.2004
P407
P577
2004-08-01T00:00:00Z